StockData
Curanex Pharmaceuticals Inc logo

Curanex Pharmaceuticals Inc (CURX) stock

CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.70+0.07 (+1.40%)

Close on Nov 17, 2026Market cap $7.37MP/E –Yield –

Curanex Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Curanex Pharmaceuticals's cash was $1.58M at Sep 30, 2026. For fiscal 2025 it was $4.97M, up 3240.1% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.97M+3240.1%
FY2024Dec 31, 2024$148.89K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.58M-72.8%
Q2 FY2026Jun 30, 2026$2.94M+2599.3%
Q1 FY2026Mar 31, 2026$4.00M+2586.5%
Q4 FY2025Dec 31, 2025$4.97M–
Q3 FY2025Sep 30, 2025$5.80M–
Q2 FY2025Jun 30, 2025$108.86K–
Q4 FY2024Dec 31, 2024$148.89K–

More Curanex Pharmaceuticals figures

See a number that looks wrong?